132 related articles for article (PubMed ID: 11566959)
1. Omapatrilat in subtotal nephrectomy-salt hypertension: role of calcitonin gene-related peptide.
Supowit SC; Zhao H; Wang DH; DiPette DJ
Hypertension; 2001 Sep; 38(3 Pt 2):697-700. PubMed ID: 11566959
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide is a depressor in subtotal nephrectomy hypertension.
Supowit SC; Zhao H; Hallman DM; DiPette DJ
Hypertension; 1998 Jan; 31(1 Pt 2):391-6. PubMed ID: 9453334
[TBL] [Abstract][Full Text] [Related]
3. Vascular reactivity to calcitonin gene-related peptide is enhanced in subtotal nephrectomy-salt induced hypertension.
Supowit SC; Katki KA; Hein TW; Gupta P; Kuo L; Dickerson IM; Dipette DJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H683-8. PubMed ID: 21666123
[TBL] [Abstract][Full Text] [Related]
4. Substance P in subtotal nephrectomy-salt hypertension.
Katki KA; Supowit SC; DiPette DJ
Hypertension; 2002 Feb; 39(2 Pt 2):389-93. PubMed ID: 11882578
[TBL] [Abstract][Full Text] [Related]
5. Role of calcitonin gene-related peptide and substance P in Dahl-salt hypertension.
Katki KA; Supowit SC; DiPette DJ
Hypertension; 2001 Sep; 38(3 Pt 2):679-82. PubMed ID: 11566955
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.
Supowit SC; Zhao H; Hallman DM; DiPette DJ
Hypertension; 1997 Apr; 29(4):945-50. PubMed ID: 9095081
[TBL] [Abstract][Full Text] [Related]
7. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and antihypertrophic effects of omapatrilat in SHR.
Burrell LM; Droogh J; Man in't Veld O; Rockell MD; Farina NK; Johnston CI
Am J Hypertens; 2000 Oct; 13(10):1110-6. PubMed ID: 11041166
[TBL] [Abstract][Full Text] [Related]
9. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
Trippodo NC; Robl JA; Asaad MM; Fox M; Panchal BC; Schaeffer TR
Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat.
Supowit SC; Zhao H; DiPette DJ
Hypertension; 2001 Feb; 37(2 Pt 2):728-32. PubMed ID: 11230364
[TBL] [Abstract][Full Text] [Related]
11. Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats.
Elmarakby AA; Morsing P; Pollock JS; Pollock DM
Vascul Pharmacol; 2003 Dec; 40(5):253-9. PubMed ID: 15259792
[TBL] [Abstract][Full Text] [Related]
12. Chronic effect of combined treatment with omapatrilat and adrenomedullin on the progression of heart failure in rats.
Nishikimi T; Mori Y; Ishimura K; Ishikawa Y; Koshikawa S; Akimoto K; Minamino N; Kangawa K; Matsuoka H
Am J Hypertens; 2006 Oct; 19(10):1039-48. PubMed ID: 17027825
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
Loch D; Hoey A; Brown L
Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.
Millette E; Demeilliers B; Wu R; Laplante MA; El Midaoui A; Moreau P; Lamontagne D; de Champlain J
J Hypertens; 2003 Jan; 21(1):125-35. PubMed ID: 12544444
[TBL] [Abstract][Full Text] [Related]
15. Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats.
Kawasaki H; Inaizumi K; Nakamura A; Hobara N; Kurosaki Y
Hypertens Res; 2003 Mar; 26(3):257-63. PubMed ID: 12675282
[TBL] [Abstract][Full Text] [Related]
16. Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension.
Quaschning T; d'Uscio LV; Shaw S; Lüscher TF
Hypertension; 2001 Apr; 37(4):1108-13. PubMed ID: 11304511
[TBL] [Abstract][Full Text] [Related]
17. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
[TBL] [Abstract][Full Text] [Related]
18. Vasopeptidase Inhibition Corrects the Structure and Function of the Small Arteries in Experimental Renal Insufficiency.
Haltia O; Törmänen S; Eräranta A; Jokihaara J; Nordhausen K; Rysä J; Ruskoaho H; Tikkanen I; Mustonen J; Pörsti I
J Vasc Res; 2015; 52(2):94-102. PubMed ID: 26184548
[TBL] [Abstract][Full Text] [Related]
19. Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats.
Jover B; Stuit L; Mimran A
J Hypertens; 2004 Feb; 22(2):383-8. PubMed ID: 15076198
[TBL] [Abstract][Full Text] [Related]
20. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
